At Gynesonics our mission is to design and develop new and advanced technologies for improving women’s health. We are focused on providing an incision-free option to women and the physicians who care for them, in treating symptomatic uterine fibroids.

Runway Growth Capital

HBM Partners

HealthCrest

Hercules Capital

InterWest Partners

Correlation Ventures

Endeavour Vision

Abingworth

Advanced Technology Ventures

Bain Capital Life Sciences

Kaiser Permanente Ventures

MVM Life Science Partners

Amzak Health Investors

Bain Capital

Gynesonics, Inc.

We're thrilled to announce a new category 1 CPT code for transcervical ablation of uterine fibroid(s), including intraoperative ultrasound guidance and monitoring, radiofrequency! 
#FibroidTreatment #SonataProcedure #CPTCode #WomensHealth 

https://bit.ly/3S6ny7y

Did you know that a hysterectomy may affect heart health? The Mayo Clinic reports that women who undergo a hysterectomy after the age of 35 face a 33% increase in the risk of coronary heart disease. For those having a hysterectomy under 35, the risk skyrockets to 250%! Stay informed and consult with your healthcare provider. 🩺 #HealthFacts #HysterectomyAwareness #HeartHealth Safety info: https://bit.ly/2LFfyHh

Attention providers: 🚨 The new CPT code for transcervical uterine fibroid ablation with ultrasound guidance using radiofrequency is now in effect! Make sure to use the new CPT code 58580. #GynecologistNews #WomensHealth #UterineFibroidAblation

"We are very pleased that the AMA has established a new Category I code that applies to our Sonata Procedure for the treatment of uterine fibroids. This unique code will simplify the process for providers and insurers of submitting and processing claims on behalf of their patients. The code is a critical milestone for the broader adoption of the technology to treat uterine fibroids in the United States." Skip Baldino President & CEO at Gynesonics, Inc.

#femtech #womenshealth #womenshealthinnovation #medtech #medicaldevices #ecosystem #healthcare #cptcodes #fibroids #health

HAPPY NEW YEAR from your South Texas Sonata Team!  Andee Burris , RDMS, CST 

We look forward to bringing an incisionless fibroid treatment option to more women in ‘24! Thank you to ALL of our Sonata surgeons leading innovation for women! #fibroids #innovationforwomen Gynesonics, Inc.

Are you at a greater risk for fibroids? #fibroidawareness #womenshealth #riskfactors Safety info: https://bit.ly/2LFfyHh

Listen to your body!  If you're experiencing pelvic pain, heavy periods, spotting between cycles, bladder issues, or ongoing fatigue, it's time to talk with a doctor. Your health matters. 💗  #WomensHealth #TrustYourBody #FibroidAwareness Safety info: https://bit.ly/2LFfyHh

Congratulations to Dr. Amy Brenner at Bethesda North Hospital for completing her first Sonata case! We're excited to see what the new year has in store for Bethesda North Hospital. #gynecologistnews #womenshealth #fibroidtreatment #sonatatreatment

Got a New Year's resolution in mind but need to boost productivity? Here are some tips to turn those goals into achievements! #ProductivityHacks #NewYearNewGoals #2024Goals Safety info: https://bit.ly/2LFfyHh

Girl, you have options! From menstrual cups to period underwear, pads, tampons, and menstrual discs. Which do you prefer? #periods #menstrualcycle #womenshealth  Safety info: https://bit.ly/2LFfyHh

Gynesonics specializes in designing and developing advanced technologies for improving women’s health, providing a safe and effective incisionless alternative to invasive surgical techniques for symptomatic uterine fibroids.

industry_trends_dossier

news_impact_assignment_basic

key_people

company_dossier

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

network

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

events

strategic_challenges

network_mapping

industry_trends

transactions_dossier

strategic_challenges_dossier

financial_statements

network_onboarding

company_summary

signals

regulatory_analysis

industry_analysis

swot_dossier

competition_analysis

financial_legal_advisories

merger_acquisitions

swot_analysis

financial_analysis

news_advanced

purchaser_profile

news_impact_assignment_advanced

news_processing_advanced

peers

news_basic

valuation

customer_profile

industry trends dossier	dataroom
company dossier	dataroom
network	dataroom
network mapping	dataroom
transactions dossier	dataroom
network onboarding	dataroom
news impact assignment basic	general
public peers	general
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
news advanced	general
news impact assignment advanced	general
news processing advanced	general
peers	general	Feb 1, 2024 2:55 PM	fe2491cd
news basic	general
events	markdown
bundesanzeiger	filings
financial statements	filings
regulatory analysis	company_analysis
industry analysis	company_analysis
competition analysis	company_analysis
financial legal advisories	company_analysis
merger acquisitions	company_analysis
swot analysis	company_analysis
financial analysis	company_analysis
purchaser profile	merger_acquisitions
customer profile	customers

COM:GYNESONICS

Gynesonics, Inc.